ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents on prescription pharmaceuticals. The company focuses on drug discovery leads that are high in certainty and globally competitive. The company was started in 1717 in Dosho-machi, Osaka. Throughout its 300-year history, ONO has dedicated itself to developing innovative and breakthrough pharmaceutical products.

Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP

Morinaga Milk Industry Co., Ltd. engages in the production and distribution of dairy products. Its operations are carried out through the following segments: Food Products and Others. The Food Products segment engages in the production and sale of milk, dairy-based beverages, yogurt, desserts, condensed milk, powdered milk, butter, cheese, ice cream, non-dairy beverages (juice, tea, coffee), and clinical liquid diets. The Others segment provides the real estate leasing services. It also engages in the manufacture and sale of animal feeds; design and construction of plant equipment. The company was founded on September 1, 1917 and is headquartered in Tokyo, Japan.

Guangzhou Trauer Biotechnology Co., Ltd. engages in the research, development, production and sale of active collagen raw materials, medical devices and biological skincare products. Its products include collagen patch dressings, collagen sponges, collagen multi-effect repair masks, and collagen multi-effect repair essences. The company was founded on August 20, 2002 and is headquartered in Guangzhou, China.

Changchun Genescience Pharmaceuticals Co., Ltd., a subsidiary of Changchun High & New Technology Industries (Group), Inc., is a company headquartered in Changchun, China. The firm manufactures pharmaceuticals products. It was founded in 1997. Lei Jin is the current CEO of the firm.

Senju Pharmaceutical Beijing Co. Ltd., part of Senju Pharmaceutical Co., Ltd., is a company headquartered in Beijing, China, that manufactures and distributes pharmaceuticals.

Matsushita Electronics Corp. develops and manufactures electronic products. Its products include plasma TVs, DVD players, and digital cameras. It is a subsidiary of Matsushita Electric Industrial Co. Ltd. The company is headquartered in Osaka, Japan.

Nanjing Drum Tower Hospital is a private company headquartered in China. The firm provides medical services.

Beijing Northland Biotech is a R&D high-tech enterprise mainly engaged in the development of therapeutic biological products.The company is a key high-tech enterprise of the National Torch Program, Beijing Science and Technology Research and Development Agency, Beijing Rare Plasmid Gene Therapy Drug Engineering Technology Research Center, and Beijing Biomedical Industry G20 Innovation Leading Enterprise with a registered capital of 112.167.676 million yuan. , stock code 430047.

R-Tech Ueno Ltd. engages in the research and development, manufacture and sale of pharmaceutical products. It operates through the following business divisions: New Pharmaceutical Research and Development, Pharmaceutical Manufacture and Sale, and Pharmaceutical Development Support and Contract Manufacturing Services. The New Pharmaceutical Research and Development business provides development for unmet medical needs area, orphan drug area, and anti-aging area. The Pharmaceutical Manufacture and Sale business handles the manufacture and sale of Rescula Eye Drops for glaucoma and ocular hypertension. The Pharmaceutical Development Support and Contract Manufacturing Services business covers the manufacture and sale of AMITIZA capsules for chronic idiopathic constipation. It also accepts contract manufacturing of eye drops, liquid drugs and liquid-filled hard capsules. The company was founded by Ryuji Ueno and Sachiko Kuno in September 1989 and is headquartered in Tokyo, Japan.

Chengdu Jingrunze Gene Technology Co., Ltd., established on 2021-05-17, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Sales of Class I Medical Devices;R&D and application of cell technology;Development of Human Gene Diagnosis and Therapy Technology;New material technology research and development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Drug retail(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).

Crist��lia Produtos Qu��micos Farmac��uticos Ltda. develops and manufactures pharmaceutical products. It offers its products for algology, primary care practice, dermatology, geriatrics, gynecology, neurology, oncology, orthopedics, psychiatry, rheumatology and urology. The company was founded in 1972 and is headquartered in Itapira, Brazil.

Nanjing Gulou Hospital is a Chinese private company located in Nanjing. The firm operates as a hospital.

Smart Eyelashes (Shenzhen) Technology Co., Ltd., established on 2021-03-19, Business scope includes general business items:computer software,Information system software development,Sales;Information system design,integrated,Operation and Maintenance;Information Technology Consulting;IC Design,research and development;Domestic Trade(Does not contain franchise,monopoly,Specially Controlled Commodities;Operating import and export business(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating);Wholesale of primary agricultural products,Sales;clothing,textile,knitwear,General merchandise wholesale,Sales;stationery,Wholesale sporting goods,Sales;Building materials wholesale,Sales;Equipment,hardware products,Wholesale of electronic products,Sales;jewelry,crafts(Except for ivory and its products)wholesale,Sales;Invest in business(Specific projects will be reported separately);Chemical Products(Free of Hazardous Chemicals),Sales of Class I medical supplies and equipment.Sales of Class I Medical Devices;Retailing of Class II Medical Devices;software sales;software development;Artificial intelligence basic software development;Artificial intelligence application software development;Software outsourcing service;Artificial intelligence theory and algorithm software development;Artificial intelligence basic resources and technology platform.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:Production and operation of medical equipment;Sales of medical equipment.Sales of Class II Medical Devices;Class III medical device business;Class II Medical Device Leasing.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Beijing Qingyuan Weiye Biological Tissue Engineering Technology Co., Ltd., established on 2001-04-28, The scope of business includes the production of Class III medical devices;Class III medical device business;medical technology development,Technology Promotion;Sales of medical devices(Class II).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Production of Class III Medical Devices,The operation of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)